Executable Network of SARS-CoV-2-Host Interaction Predicts Drug Combination Treatments

Matthew A. Clarke, Rowan Howell, Ann-Kathrin Reuschl, Tianyi Chen, Sean Abbott-Imboden, Mervyn Singer, David M. Lowe, Clare L. Bennett, Benjamin Chain, Clare Jolly, Jasmin Fisher
Project

Date
May 10, 2022 9:30 AM
Event
Biochemical Society Scientific Drug Repurposing II
Location
Woburn House, London, UK
Tavistock Square, London, WC1H 9HQ
BMA Combination Therapy COVID-19
Matthew A. Clarke
Matthew A. Clarke
Research Scientist, Associate Staff Visitor

Research Scientist at the AI Security Institute and Associate Staff Visitor at UCL.